[Malabsorption and cancer].
D000970:Antineoplastic Agents / Q000009:adverse effects; D001984:Bronchial Neoplasms / Q000150:complications; D002446:Celiac Disease / Q000150:complications / Q000175:diagnosis / Q000209:etiology; D003937:Diagnosis, Differential; D003967:Diarrhea / Q000209:etiology; D004938:Esophageal Neoplasms / Q000209:etiology; D005729:Ganglioneuroma / Q000150:complications; D006689:Hodgkin Disease / Q000150:complications / Q000175:diagnosis / Q000209:etiology; D006801:Humans; D007414:Intestinal Neoplasms / Q000209:etiology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000209:etiology; D008228:Lymphoma, Non-Hodgkin / Q000209:etiology; D008286:Malabsorption Syndromes / Q000139:chemically induced / Q000150:complications* / Q000209:etiology; D009369:Neoplasms / Q000150:complications* / Q000209:etiology / Q000532:radiotherapy / Q000601:surgery; D009506:Nevus / Q000150:complications; D010190:Pancreatic Neoplasms / Q000150:complications; D011183:Postoperative Complications; D013274:Stomach Neoplasms / Q000150:complications; D013964:Thyroid Neoplasms / Q000150:complications
D000970:Antineoplastic Agents
Malabsorption und Krebs.